Back to Journals » Cancer Management and Research » Volume 18
Ginseng-Derived Exosomes Attenuate Immune Evasion in NSCLC via PD-L1 Modulation [Corrigendum]
Zhu LJ, Chen XQ, Lin QY, Feng JN, Yuan SF. Cancer Manag Res. 2025;17:1503–1512.
The authors have advised that they neglected to include a funding statement on page 1511 of the published paper. The funding statement should read as follows.
FundingThis study was supported by Zhejiang Province traditional Chinese medicine health research project (2024ZL165) and Wenzhou science and technology program (Y2023392).
The authors apologize for this error.
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.